The FDA has granted 510(k) clearance to Hotspur Technologies for its IQCath and GPSCath balloon dilatation catheters and Keeper embolectomy catheter, which are meant to improve dialysis access by helping to open clogged blood vessels in the arms and legs. The company plans to launch the three devices by the end of the year.

Related Summaries